Handling uncertainty in economic evaluations of healthcare interventionsBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7210.635 (Published 04 September 1999) Cite this as: BMJ 1999;319:635
- Andrew H Briggs, training fellow ([email protected]),
- Alastair M Gray, reader
- Health Economics Research Centre, Institute of Health Sciences, University of Oxford, Oxford OX3 7LF
- Correspondence to: A H Briggs
This is the last of four articles
The constant introduction of new health technologies, coupled with limited healthcare resources, has engendered a growing interest in economic evaluation as a way of guiding decision makers towards interventions that are likely to offer maximum health gain. In particular, cost effectiveness analyses—which compare interventions in terms of the extra or incremental cost per unit of health outcome obtained—have become increasingly familiar in many medical and health service journals.
Considerable uncertainty exists in regard to valid economic evaluations Firstly, several aspects of the underlying methodological framework are still being debated among health economists. Secondly, there is often considerable uncertainty surrounding the data, the assumptions that may have been used, and how to handle and express this uncertainty. In the absence of data at the patient level sensitivity analysis is commonly used; however, a number of alternative methods of sensitivity analysis exist, with different implications for the interval estimates generated (see box). Finally, there is a substantial amount of subjectivity in presenting and interpreting the results of economic evaluations.
The aim of this paper is to give an overview of the handling of uncertainty in economic evaluations of healthcare interventions.3 It examines how analysts have handled uncertainty in economic evaluation, assembled data on the distribution and variance of healthcare costs, and proposed guidelines to improve current practice. It is intended as a contribution towards the development of agreed guidelines for analysts, reviewers, editors, and decision makers.4–7
Economic evaluations are beset by uncertainty concerning methodology and data
A review of 492 articles published up to December 1996 found that a fifth did not attempt any analysis to examine uncertainty
Only 5% of these studies reported some measure of cost variance
Closer adherence to published guidelines would greatly improve the current position
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial